Recently added
This page was added on 04 June 2018.
Updates made
This page was updated on [date-counter-updated-date]. View history of updates
Sponsor
Merck Sharp & Dohme (Australia)
Administration route
Intramuscular injection
Subcutaneous injection
Vaccine group
Pneumococcal polysaccharide vaccine
Description:
Registered for use in children aged ≥2 years and in adults.
23vPPV — 23-valent pneumococcal polysaccharide vaccine
Each 0.5 mL monodose vial contains:
- 25 µg each of pneumococcal capsular polysaccharide of serotypes 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F and 33F
- 0.25% phenol
For Product Information and Consumer Medicine Information about Pneumovax 23 visit the Therapeutic Goods Administration website.
Additional vaccine information
For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.
Page history
Last updated
Last reviewed
Related diseases